The Safewards study lacks rigour despite its randomised design

International Journal of Nursing Studies

Volumn 52, Issue 12, 2015, Pages 1906-1907

  Mustafa, Feras Ali ^a  

^a Northamptonshire Healthcare NHS Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METHODOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDS;

RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84960797239     PISSN: 00207489     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijnurstu.2015.09.002     Document Type: Note

References (9)

1. Bowers L., James K., Quirk A., Simpson A., SUGAR, Stewart D., Hodsoll J. Reducing conflict and containment rates on acute psychiatric wards: the Safewards cluster randomised controlled trial. Int. J. Nurs. Stud. 2015, 52:1412-1422.
2. Burns T. Where are the hypotheses when you need them?. Br. J. Psychiatry 2012, 201:178-179.
3. Cartwright N. Are RCTs the gold standard?. BioSocieties 2007, 2:11-20.
4. Hill A.B. Suspended judgment. Memories of the British Streptomycin Trial in Tuberculosis. The first randomized clinical trial. Control Clin. Trials 1990, 11:77-79.
5. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., VittinghoffE. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998, 280:605-613.
6. Jauhar S., McKenna P.J., Radua J., Fung E., Salvador R., Laws K.S. Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Br. J. Psychiatry 2014, 204:20-29.
7. Kotaska A. Inappropriate use of randomised trials to evaluate complex phenomena: case study of vaginal breech delivery. BMJ 2004, 329:1039-1042.
8. Mustafa F.A. On the OCTET and supervised community treatment orders. Med. Sci. Law 2014, 54:116-117.
9. Noseworthy J.H., Ebers G.C., Vandervoort M.K., Farquhar R.E., Yetisir E., Roberts R. The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis trial. Neurology 1994, 44:16-20.